| 000 | 00817 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250515171302.0 | ||
| 264 | 0 | _c20090603 | |
| 008 | 200906s 0 0 eng d | ||
| 022 | _a1546-1696 | ||
| 024 | 7 |
_a10.1038/nbt0509-420 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMertz, Alan | |
| 245 | 0 | 0 |
_aRegulating laboratory-developed tests. _h[electronic resource] |
| 260 |
_bNature biotechnology _cMay 2009 |
||
| 300 |
_a420-1 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 | _aDiagnostic Tests, Routine |
| 650 | 0 | 4 | _aPharmacogenetics |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 773 | 0 |
_tNature biotechnology _gvol. 27 _gno. 5 _gp. 420-1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/nbt0509-420 _zAvailable from publisher's website |
| 999 |
_c18858438 _d18858438 |
||